Company intelligence / Profile preview

Shanghai Hongdian Medical

Shanghai, Shanghai, Chinasigma.larvol.com ↗

Ownership: Private
Development stage: Other

Overview

Shanghai Hongdian Medical Technology Co., Ltd. is developing a renal artery radiofrequency (RF) ablation system and has recently enrolled the first patient in its clinical study. The company appears to be focused on interventional medical devices targeting cardiovascular or renal indications.

Therapeutic areas: Cardiovascular
Modalities: DeviceRadiofrequency ablation system (medical device)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Shanghai Hongdian Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Hongdian Medical.

Explore the full profile